EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Propensity score analysis for the efficacy of preoperative antibiotics in patients with resected primary lung cancer: Levofloxacin versus cefazolin

Kenji Tomizawa, Junichi Soh, Hana Oiki, Shota Fukuda, Masaya Nishino, Katsuaki Sato, Tetsuya Mitsudomi

Clinical Surgical Oncology · 2022

DOI: 10.1016/j.cson.2022.100005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Surgical Oncology, 2022. Verfasst von Kenji Tomizawa und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Tomizawa, K., Soh, J., Oiki, H., Fukuda, S., Nishino, M., Sato, K., & Mitsudomi, T. (2022). Propensity score analysis for the efficacy of preoperative antibiotics in patients with resected primary lung cancer: Levofloxacin versus cefazolin. Clinical Surgical Oncology. https://doi.org/10.1016/j.cson.2022.100005

Vancouver

Tomizawa K, Soh J, Oiki H, Fukuda S, Nishino M, Sato K, et al. Propensity score analysis for the efficacy of preoperative antibiotics in patients with resected primary lung cancer: Levofloxacin versus cefazolin. Clinical Surgical Oncology. 2022. doi:10.1016/j.cson.2022.100005

BibTeX
@article{Tomizawa2022,
  author = {Tomizawa, Kenji and Soh, Junichi and Oiki, Hana and Fukuda, Shota and Nishino, Masaya and Sato, Katsuaki and Mitsudomi, Tetsuya},
  title = {Propensity score analysis for the efficacy of preoperative antibiotics in patients with resected primary lung cancer: Levofloxacin versus cefazolin},
  journal = {Clinical Surgical Oncology},
  year = {2022},
  doi = {10.1016/j.cson.2022.100005}
}
Kostenlos starten →